What was the overall market valuation of the US ascites market in 2024?

The overall market valuation was $336.4 Million in 2024. Read More

What is the projected market valuation for the US ascites market by 2035?

The projected valuation for 2035 is $745.25 Million. Read More

What is the expected CAGR for the US ascites market during the forecast period 2025 - 2035?

The expected CAGR for the US ascites market during the forecast period 2025 - 2035 is 7.5%. Read More

Which companies are considered key players in the US ascites market?

Key players in the market include Bristol-Myers Squibb, Roche, Novartis, Gilead Sciences, Merck & Co., Amgen, AbbVie, and Johnson & Johnson. Read More

What were the market values for Transudative and Exudate Ascites in 2024?

In 2024, Transudative Ascites was valued at $201.84 Million, while Exudate Ascites was valued at $134.56 Million. Read More

What are the projected market values for Ultrasound and CT scan diagnostics by 2035?

By 2035, Ultrasound is projected to reach $115.0 Million, and CT scan diagnostics may reach $160.0 Million. Read More

What treatment segments are included in the US ascites market, and what were their values in 2024?

The treatment segments include Medication at $134.4 Million, Paracentesis at $100.0 Million, and Surgery at $102.0 Million in 2024. Read More

What is the market value for the Oral route of administration in 2024?

The market value for the Oral route of administration was $67.92 Million in 2024. Read More

What are the projected values for Hospital Pharmacies and Retail Pharmacies by 2035?

By 2035, Hospital Pharmacies are projected to reach $225.0 Million, while Retail Pharmacies may reach $270.0 Million. Read More

What were the market values for Home Care and Specialty Clinics in 2024?

In 2024, Home Care was valued at $101.84 Million, and Specialty Clinics were valued at $100.0 Million. Read More

US Ascites Market

ID: MRFR/MED/13959-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Ascites Market Research Report By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) and By End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Industrial Automation & Equipment, BY Type (USD Million)
  1. 4.1.1 Transudative Ascites
  2. 4.1.2 Exudate Ascites
2. 4.2 Industrial Automation & Equipment, BY Diagnosis (USD Million)
  1. 4.2.1 Ultrasound
  2. 4.2.2 CT scan
  3. 4.2.3 MRI
  4. 4.2.4 Blood test
  5. 4.2.5 Laparoscopy
  6. 4.2.6 Angiography
3. 4.3 Industrial Automation & Equipment, BY Treatment (USD Million)
  1. 4.3.1 Medication
  2. 4.3.2 Paracentesis
  3. 4.3.3 Surgery
4. 4.4 Industrial Automation & Equipment, BY Route of Administration (USD Million)
  1. 4.4.1 Oral
  2. 4.4.2 Parenteral
  3. 4.4.3 Others
5. 4.5 Industrial Automation & Equipment, BY End-users (USD Million)
  1. 4.5.1 Hospitals
  2. 4.5.2 Specialty Clinics
  3. 4.5.3 Home Care
6. 4.6 Industrial Automation & Equipment, BY Allotment Channel (USD Million)
  1. 4.6.1 Hospital Pharmacies
  2. 4.6.2 Retail Pharmacies
  3. 4.6.3 Online Pharmacies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Bristol-Myers Squibb (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Novartis (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Gilead Sciences (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Merck & Co. (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Amgen (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 AbbVie (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Johnson & Johnson (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY DIAGNOSIS
4. 6.4 US MARKET ANALYSIS BY TREATMENT
5. 6.5 US MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
6. 6.6 US MARKET ANALYSIS BY END-USERS
7. 6.7 US MARKET ANALYSIS BY ALLOTMENT CHANNEL
8. 6.8 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
9. 6.9 RESEARCH PROCESS OF MRFR
10. 6.10 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
11. 6.11 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
12. 6.12 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
13. 6.13 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 (% SHARE)
15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TYPE, 2024 TO 2035 (USD Million)
16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DIAGNOSIS, 2024 (% SHARE)
17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DIAGNOSIS, 2024 TO 2035 (USD Million)
18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT, 2024 (% SHARE)
19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT, 2024 TO 2035 (USD Million)
20. 6.20 INDUSTRIAL AUTOMATION & EQUIPMENT, BY ROUTE OF ADMINISTRATION, 2024 (% SHARE)
21. 6.21 INDUSTRIAL AUTOMATION & EQUIPMENT, BY ROUTE OF ADMINISTRATION, 2024 TO 2035 (USD Million)
22. 6.22 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END-USERS, 2024 (% SHARE)
23. 6.23 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END-USERS, 2024 TO 2035 (USD Million)
24. 6.24 INDUSTRIAL AUTOMATION & EQUIPMENT, BY ALLOTMENT CHANNEL, 2024 (% SHARE)
25. 6.25 INDUSTRIAL AUTOMATION & EQUIPMENT, BY ALLOTMENT CHANNEL, 2024 TO 2035 (USD Million)
26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY DIAGNOSIS, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY ROUTE OF ADMINISTRATION, 2025-2035 (USD Million)
  5. 7.2.5 BY END-USERS, 2025-2035 (USD Million)
  6. 7.2.6 BY ALLOTMENT CHANNEL, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Type (USD Million, 2025-2035)

Transudative Ascites
Exudate Ascites

Industrial Automation & Equipment By Diagnosis (USD Million, 2025-2035)

Ultrasound
CT scan
MRI
Blood test
Laparoscopy
Angiography

Industrial Automation & Equipment By Treatment (USD Million, 2025-2035)

Medication
Paracentesis
Surgery

Industrial Automation & Equipment By Route of Administration (USD Million, 2025-2035)

Oral
Parenteral
Others

Industrial Automation & Equipment By End-users (USD Million, 2025-2035)

Hospitals
Specialty Clinics
Home Care

Industrial Automation & Equipment By Allotment Channel (USD Million, 2025-2035)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”